Close Menu

NEW YORK ─ The US Food and Drug Administration, which continued to review and grant Emergency Use Authorizations for SARS-CoV-2 testing in June, also granted 510(k) clearances for tests from a handful of in vitro diagnostic companies, including Siemens Healthineers, EKF Diagnostics, Immucor, Horiba, and others, according to the agency's website.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.